Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

PDS Biotechnology completes phase I study for PDS-0101

April 14, 2016

Phase I/II trial of TG-01 shows immune response with reduced number of vaccinations

April 14, 2016

Oncternal Therapeutics receives license to develop ROR1 antibodies

April 13, 2016

Positive interim review in ongoing AML WT1 T cell clinical trial

April 13, 2016

Enrollment open in phase I study of MIW-815 for advanced cancers

April 12, 2016

Celgene exercises option to develop and commercialize Juno's CD19-directed drug candidates

April 12, 2016

Altor BioScience and NCI partner to develop cancer immunotherapeutics

April 12, 2016

MSD K.K. and Taiho sign copromotion agreement for pembrolizumab in Japan

April 11, 2016

Pritumumab receives FDA orphan drug designation for the treatment of pancreatic cancer

April 11, 2016

FDA grants priority review to atezolizumab BLA in NSCLC

April 11, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...